Meet Our Featured Speakers

benefits

mRNA Conference USA 2026 offers expert-driven market intelligence and industry insights into next-generation mRNA therapeutics, advanced formulations, and clinical progress.

Benefits of attending include:

Two days of in-depth presentations featuring the latest market intelligence, addressing key priorities in the pharmaceutical industry, and showcasing results and insights.
Exclusive networking opportunities to connect with professionals navigating similar challenges in this rapidly evolving sector.
Gain insights into regional projects and research led by leading vaccination experts and manufacturers, highlighting their experiences, findings, and innovative proposals.
Technical presentations from vaccine developers highlighting recent trial results, technological advancements, and emerging expertise.
New case studies featuring insights from leading industry experts on global vaccine and therapeutic development initiatives.
A unique opportunity to collaborate with diverse manufacturers and explore new market opportunities through valuable insights into this dynamic industry.

key takeaways

Gain insights into current market dynamics within the biotech and pharmaceutical industries
Learn to create effective strategies for vaccine design and development
Explore the latest trends through a comprehensive review of the past year, along with future projections for the biotech and pharmaceutical industries
Examine innovations and technological advancements in vaccine delivery aimed at enhancing immune responses
Engage with expert perspectives and valuable insights from allied industries, including regional experiences and best practices

who should attend?

This conference is intended for leading biotech and pharmaceutical companies, government agencies, and policy think tanks interested in exploring mRNA-based therapeutics and vaccines for infectious diseases, oncology, and CAR T-cell therapies.

Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, and Managers involved in:

mRNA Experts mRNA Manufacturing Business Development RNA Experts CAR-T Cell Experts Clinical Trials and Approvals Drug Discovery Vaccine Experts Manufacturing Biotherapeutics and Biologics Clinical Diagnostics Research and Development Biotechnology Researchers Companion Diagnostics Strategy and Public Policy Nanotechnologies Theragnostic Sales and Marketing Initiatives Nano and Micro Robotics RNA Medicine Legal and Regulatory Modalities Research Precision Medicine Equipment Certification Services

they've attended our events

Lingyao Li

Sanofi

"A highly efficient conference with valuable communication and discussions."

Jennifer Carl

Velocity Clinical Research

"Packed with excellent speakers."

Xinhua Yan

Moderna, Inc.

"Fantastic speakers and location with a strong schedule."

Ami Jo

Omega Therapeutics, Inc.

"The event showcased the key elements in drug product development."

Adam Brausa

Morrison Foerster

"Great content, I gained a lot."

Asim Abdul

GSK

"The forum offered strong insight into the mRNA platform."

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.